Bufylline
RESPIRATORY SYSTEM
Also known as: ambuphylline, butaphyllamine, theophylline aminoisobutanol
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bufylline is a drug catalogued in DrugCentral. DrugCentral lists 20 molecular targets, including ADORA2A, ADORA1 and ADORA3.
- Molecular targets: ADORA2A, ADORA1, ADORA3 and Adora1 (20 listed in DrugCentral).
- ATC code: R03DA10 (Xanthines).
Mechanism & targets
Molecular targets (20)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Adenosine receptor A2a | ADORA2A | antagonist | Ki 9.22 |
| Adenosine receptor A1 | ADORA1 | antagonist | Ki 9.22 |
| Adenosine receptor A3 | ADORA3 | antagonist | Ki 7.85 |
| Adenosine receptor A1 | Adora1 | unknown | Ki 6.15 |
| Adenosine A2 receptor | Adora2b|Adora2a | unknown | Ki 5.88 |
| Adenosine receptor A2b | ADORA2B | antagonist | Ki 5.57 |
| Adenosine receptor A1 | ADORA1 | unknown | Ki 5.42 |
| Adenosine receptor A2a | Adora2a | unknown | Ki 5.17 |
| Adenosine receptor A1 | ADORA1 | unknown | Ki 5.01 |
| Adenosine A2a receptor | ADORA2A | unknown | Ki 4.89 |
| Adenosine A2 receptor | ADORA2A|ADORA2B | antagonist | Ki 4.85 |
| Adenosine A2b receptor | Adora2b | unknown | Ki 4.82 |
| Adenosine receptor | Adora1|Adora3|Adora2b|Adora2a | unknown | Ki 4.70 |
| Phosphodiesterase 4 | PDE4A|PDE4B|PDE4C|PDE4D | inhibitor | Ki 4.25 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | PIK3CD | unknown | IC50 4.12 |
| Uncharacterized protein | PDE3B | unknown | Ki 4.11 |
| Alkaline phosphatase, tissue-nonspecific isozyme | ALPL | unknown | Ki 4.09 |
| Adenosine receptor A3 | Adora3 | unknown | Ki 4.07 |
| Heart phosphodiesterase | PDE3B|PDE1A|PDE1B | unknown | IC50 4.04 |
| Phosphodiesterase 3 | PDE3B|PDE3A | inhibitor | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R03DA10 | RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › Xanthines |
Chemical structure
| Molecular formula | — |
|---|---|
| Molecular weight | — |
| CAS number | — |
| InChIKey | — |
| PubChem CID | 21850 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Bufylline work?
Its molecular targets in DrugCentral include ADORA2A (antagonist), ADORA1 (antagonist), ADORA3 (antagonist) and Adora1.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4426 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104089 — compound record and bioactivity
- PubChem CID 21850 — chemical identifiers
- DrugBank DB13812 — drug record
- FDA UNII VOU5V0B772 — substance identity
- UniProt P29274 (ADORA2A) — target protein
- UniProt P30542 (ADORA1) — target protein
- UniProt P0DMS8 (ADORA3) — target protein
- UniProt P29275 (ADORA2B) — target protein
- UniProt O00329 (PIK3CD) — target protein
- UniProt P05186 (ALPL) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.